Remove Bioinformatics Remove Cardiology Remove Research
article thumbnail

How Phosphorus’ GeneCompass Preventative Genetic Test Can Help People Manage Their Health

XTalks

The technology powering GeneCompass is already in use by some well-known commercial laboratories, research institutions, fertility clinics and hospitals,” said Alexander Bisignano, Phosphorus co-founder and CEO, in a press release. “We The Phosphorus GeneCompass test has a list price of $249.

article thumbnail

Researchers release analysis of largest, most diverse genetic data set

Scienmag

Data demonstrates new increased diversity in genetic studies and provides new insights into population-specific diseases Researchers at the University of Maryland School of Medicine (UMSOM) and their colleagues published a new analysis today in the journal Nature from genetic sequencing data of more than 53,000 individuals, primarily from minority (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Improving European healthcare through cell-based interceptive medicine

Scienmag

Credit: Felix Petermann, MDC Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare.

article thumbnail

FDA grants breakthrough device designation for atrial fibrillation ECG analysis platform

Scienmag

Platform developed by Tempus, Geisinger CHICAGO, March 24, 2020 — Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG Analysis Platform, developed in collaboration with Geisinger.